25.30
+0.45
+(1.81%)
At close: 1:30:35 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
65,774.00
84,782.00
1,510.00
-17,259.00
87,079.00
Investing Cash Flow
14,593.00
-78,683.00
-5,747.00
36,896.00
-15,100.00
Financing Cash Flow
-37,902.00
-20,232.00
-39.00
-44,409.00
-49,435.00
End Cash Position
223,913.00
180,032.00
194,165.00
198,441.00
223,213.00
Capital Expenditure
-28,369.00
-33,343.00
-24,014.00
-18,134.00
-27,159.00
Issuance of Capital Stock
--
--
38,883.00
--
--
Free Cash Flow
37,405.00
51,439.00
-22,504.00
-35,393.00
59,920.00
12/31/2020 - 12/28/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
3205.TWO Sagittarius Life Science Corp
33.95
-1.59%
3176.TWO Medigen Biotechnology Corp.
32.60
-1.21%
4167.TWO Savior Lifetec Corporation
19.75
-0.25%
4147.TWO TaiMed Biologics Inc.
86.50
+0.35%
6535.TWO Lumosa Therapeutics Co., Ltd.
263.50
-0.57%
4133.TW Abnova (Taiwan) Corporation
29.80
-1.16%
4142.TW Adimmune Corporation
22.60
-1.74%
4162.TWO PharmaEngine, Inc.
95.10
+2.15%
6547.TWO Medigen Vaccine Biologics Corporation
47.60
-3.94%
6492.TWO Senhwa Biosciences, Inc.
42.35
+0.47%